European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading

European equities traded in the US as American depositary receipts edged lower late Monday morning, declining 0.12% to 1,470.85 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and semiconductor company Sequans Communications (SQNS), which rose 3.8% and 3.5% respectively. They were followed by biotech firm BioNTech (BNTX) and telecommunications operator Telefonica (TEF), which were up 1.4% and 1.1% respectively.

The decliners from continental Europe were led by medical device maker EDAP (EDAP) and biopharmaceutical company DBV Technologies (DBVT), which dropped 6.4% and 4.2% respectively. They were followed by furniture maker Natuzzi (NTZ) and internet browser company Opera (OPRA), which fell 3.9% and 3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 5.8% and 5.4% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were up 1.7% each.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and biotech firm Autolus Therapeutics (AUTL), which fell 5.1% and 3% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and TC Biopharm (TCBP), which were down 2.6% and 1.5% respectively.